NCT06369714View on ClinicalTrials.gov

Neurofeedback-Based Digital Therapeutics for the Diagnosis and Treatment of ADHD in Children.

NARecruitingINTERVENTIONAL
Enrollment

210

Participants

Timeline

Start Date

February 24, 2023

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Attention Deficit Disorder With HyperactivityExecutive Function Disorder
Interventions
DRUG

Concerta

Methylphenidate Hydrochloride Extended-Release Tablets with the following specifications: 18mg dosage, oral administration, once a day for a duration of 8 weeks.

DEVICE

Digital therapeutics

30 sessions of digital therapeutics, each lasting 30 minutes, will be conducted with a frequency of once every 1-2 days over an 8-week period.

Trial Locations (2)

200003

RECRUITING

Changzheng Hospital, Naval Medical University, Shanghai

200433

RECRUITING

Changhai Hospital, Naval Medical University, Shanghai

All Listed Sponsors
lead

Lei Lei, MD

OTHER